Headline News about Reata Pharma
![](https://g.foolcdn.com/editorial/images/739109/scientist-in-a-lab.jpeg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2016/02/KPBLOG01-022916-shutterstock.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/06/IT03-reata-04-news.jpg)
![](https://www.investors.com/wp-content/uploads/2018/03/Stock-Pharma-6-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2021/10/wall-street-bull.jpg)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-biotech-011-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/15/john_wiley__sons_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/06/A1-060523-Bigpharma-chrisgash.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/10/reta.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/05/IT02-REATApharmaceuticals-02-news.jpg)
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-biohavenpharma-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/24/abercrombie__fitch_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_8938.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Reata Pharmaceuticals Q1 Earnings
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Reata Pharmaceuticals
May 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_8651.png?width=1200&height=800&fit=crop)
Where Reata Pharmaceuticals Stands With Analysts
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Reata Pharmaceuticals Stands With Analysts
March 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/10/image_3.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://g.foolcdn.com/editorial/images/723685/happy-investor.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/727669/happy-investor-stock-chart-getty.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.